SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-07-095958
Filing Date
2007-04-30
Accepted
2007-04-30 16:17:39
Documents
4
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 1 d10ka.htm 10-K/A 404023
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6554
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6005
4 GRAPHIC g42513logo001.jpg GRAPHIC 10970
  Complete submission text file 0001193125-07-095958.txt   433339
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-19756 | Film No.: 07800688
SIC: 2836 Biological Products, (No Diagnostic Substances)